Sec. 17744e.
(1) Notwithstanding any provision of this act to the contrary, the chief medical executive in the office of chief medical executive created within the department of health and human services may issue a standing order that does not identify particular patients at the time it is issued for any of the following purposes:
(a) A pharmacist dispensing opioid antagonists to individuals under this section.
(b) A community-based organization or a staff member of the community-based organization distributing opioid antagonists to individuals under this section.
(2) Notwithstanding any provision of this act to the contrary, a pharmacist may dispense or a community-based organization or a staff member of the community-based organization may distribute an opioid antagonist to any individual pursuant to a standing order issued by the chief medical executive under subsection (1) and the rules promulgated under this section.
(3) The following are not liable in a civil action for damages resulting from the dispensing of an opioid antagonist or the administration of or failure to administer the opioid antagonist:
(a) The chief medical executive who issues a standing order for the opioid antagonist under this section.
(b) A pharmacist who dispenses the opioid antagonist as authorized under this section.
(c) A community-based organization that, or a staff member of the community-based organization who, distributes the opioid antagonist as authorized under this section.
(4) The department, in consultation with the department of health and human services and local health departments, may promulgate rules regarding dispensing, training, distribution, and referral to implement this section.
(5) As used in this section, "community-based organization" means a public or private organization that provides health or human services to meet the needs of a community, including, but not limited to, a nonprofit organization, a social service provider, or an organization providing substance use disorder prevention, treatment, recovery, or harm reduction services. A community-based organization does not include an agency as that term is defined in section 101 of the administration of opioid antagonists act, 2019 PA 39, MCL 15.671.
History: Add. 2016, Act 383, Eff. Mar. 28, 2017 ;-- Am. 2022, Act 176, Imd. Eff. July 21, 2022 Compiler's Notes: For transfer of powers and duties of chief medical executive to the new chief medical executive in the office of chief medical executive created within the department of health and human services, and abolishment of the position of chief medical executive, see E.R.O. No. 2016-4, compiled at MCL 333.26369.Popular Name: Act 368
Structure Michigan Compiled Laws
Act 368 of 1978 - Public Health Code (333.1101 - 333.25211)
Article 15 - Occupations (333.16101...333.18838)
368-1978-15-177 - Part 177 Pharmacy Practice and Drug Control (333.17701...333.17780)
Section 333.17702 - Definitions; a to C.
Section 333.17703 - Definitions; D, E.
Section 333.17704 - Definitions; F to I.
Section 333.17705 - Definitions; L.
Section 333.17706 - Definitions; M, O.
Section 333.17707 - Definitions; P.
Section 333.17708 - Definitions; P to R.
Section 333.17709 - Definitions; S to W.
Section 333.17721 - Michigan Board of Pharmacy; Creation; Membership; Terms.
Section 333.17722 - Michigan Board of Pharmacy; Duties Generally.
Section 333.17726 - Certificate of Licensure; Issuance.
Section 333.17733 - Relicensure of Pharmacist; Requirements.
Section 333.17737 - Rules Establishing Standards for Internship Program; Limited License Required.
Section 333.17739 - Pharmacy Technician; Functions; Licensure.
Section 333.17739b - Pharmacy Technician; Temporary License.
Section 333.17739c - Pharmacy Technician; Limited License.
Section 333.17742 - Disclosure; "Applicant" Defined.
Section 333.17742a - Remote Pharmacy; Operation; Licensure Requirements; Location Waiver; Exception.
Section 333.17743 - Pharmacy License; Contents; Duration.
Section 333.17744a - Auto-Injectable Epinephrine; Prescribing or Issuing to Authorizing Entity.
Section 333.17744b - Prescribing, Possessing, or Dispensing Opioid Antagonist; Liability.
Section 333.17748c - Compounding Pharmaceutical; Commercial Availability.
Section 333.17748d - Violation of MCL 333.17748a or 17748b; Penality.
Section 333.17750a - Dispensing of Prescription for Therapeutic Pharmaceutical Agent by Pharmacist.
Section 333.17756 - Label on Prescription; Contents.
Section 333.17757b - Contracts With Pharmacy Benefit Managers; Prohibited Terms.
Section 333.17758 - Repealed. 1986, Act 304, Eff. Mar. 31, 1987.
Section 333.17759 - Dispensing Harmful Drug; Requirements.
Section 333.17761 - Display of Notice; Dispensing Prescription in Safety Closure Container.
Section 333.17762 - Misbranded Prescription.
Section 333.17764 - Conduct Constituting Misdemeanor; Violation; Penalty; Other Violations.
Section 333.17766 - Additional Conduct Constituting Misdemeanor.
Section 333.17766a - Repealed. 2001, Act 236, Imd. Eff. Jan. 3, 2002.
Section 333.17766b - Repealed. 2001, Act 231, Eff. Jan. 6, 2003.
Section 333.17767 - Rules and Determinations as to Licensing.
Section 333.17770 - Exceptions.
Section 333.17776 - Destruction and Disposal of Certain Drugs and Medications.